Skip to main content
Dana Lukin, MD, Gastroenterology, New York, NY

DanaLukinMDPhD

Gastroenterology • New York, NY

Inflammatory Bowel Disease

Associate Professor of Medicine

Request Appointment

Overview of Dr. Lukin

Dr. Dana Lukin, based in New York, NY, specializes in Gastroenterology with a sub-specialty in Inflammatory Bowel Disease. His education includes both MD and PhD degrees from Icahn School of Medicine at Mount Sinai, with a residency in Internal Medicine at the same institution. He completed a fellowship in Gastroenterology at New York Presbyterian Hospital. Currently, he serves as an Attending Physician at New York-Presbyterian Hospital and as an Assistant Professor at Weill Cornell Medicine, after a tenure at Montefiore Medical Center. He possesses expertise in inflammatory bowel disease, ulcerative colitis, Crohn's disease, and endoscopy. Dr. Lukin has authored several notable publications in his field, and he is actively involved in clinical trials examining vaccination adherence among IBD patients and the effect of time-restricted feeding on Crohn's Disease.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2010 - 2013
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2007 - 2010
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2007, MD, PhD

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2008 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
    Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
  • Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
    Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature

Press Mentions

  • List of Advanced Rx Recommended For Moderate to Severe UC Expands
    List of Advanced Rx Recommended For Moderate to Severe UC ExpandsFebruary 4th, 2025
  • Inpatient Monitoring May Extend Hospital Stays in Acute Severe Ulcerative Colitis
    Inpatient Monitoring May Extend Hospital Stays in Acute Severe Ulcerative ColitisJuly 30th, 2024
  • Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitis
    Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative ColitisDecember 2nd, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Dr. Dana Lukin, Dr. Dana Lukin, MD, Dr. D Lukin